> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Sanders to Introduce Generic Drug Bill
- URL: https://www.fdaweb.com/sanders-to-introduce-generic-drug-bill/
- Published: 2019-01-10T12:00:00.000Z
- Updated: 2026-09-15T00:53:35.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5143127

Sen. **Bernie Sanders** (I-VT) and Rep. **Ro Khanna** (D-CA) will introduce the Prescription Drug Price Relief Act of 2019 to require the HHS secretary to license generic and biosimilar competition on patented prescription products when they are deemed excessively priced or cost more than the median in Canada, the UK, Germany, France, and Japan. In a [statement](https://www.citizen.org/media/press-releases/legislation-would-deliver-relief-pharma-rip-offs-through-generic-competition?ref=fdaweb.com) announcing the legislation, Public Citizen president **Robert Weissman** says American consumers pay too much for prescription drugs “not because it is expensive to manufacture them or even because of research and development. We pay too much because the U.S. government grants patents and other monopolies to brand-name manufacturers, then stands aside as Big Pharma exploits these monopolies to price gouge consumers and the government itself.”